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ABSTRACT Naturalkiller(NK)cellsareequippedtoinnatelyproducethecytokinegammainterferon(IFN-)inpartbecause
theybasallyexpresshighlevelsofthesignaltransducerandactivatoroftranscription4(STAT4).Type1interferons(IFNs)have
thepotentialtoactivateSTAT4andpromoteIFN-expression,butconcurrentinductionofelevatedSTAT1negativelyregulates
accesstothepathway.Asaconsequence,ithasbeendifﬁculttodetecttype1IFNstimulationofNKcellIFN-duringviralinfec-
tionsinthepresenceofSTAT1andtounderstandtheevolutionaryadvantageformaintainingthepathway.Thestudiesreported
hereevaluatedNKcellresponsesfollowinginfectionswithlymphocyticchoriomeningitisvirus(LCMV)inthecompartment
handlingtheearliesteventsafterinfection,theperitonealcavity.Theproductionoftype1IFNs,bothIFN-andIFN-,was
showntobeearlyandofshortduration,peakingat30hafterchallenge.NKcellIFN-expressionwasdetectedwithoverlapping
kineticsandrequiredactivatingsignalsdeliveredthroughtype1IFNreceptorsandSTAT4.Ittookplaceunderconditionsof
highSTAT4levelsbutprecededelevatedSTAT1expressioninNKcells.TheIFN-responsereducedviralburdens.Interestingly,
increasesinSTAT1weredelayedinNKcellscomparedtootherperitonealexudatecell(PEC)populations.Takentogether,the
studiesdemonstrateanovelmechanismforstimulatingIFN-productionandelucidateabiologicalrolefortype1IFNaccessto
STAT4inNKcells.
IMPORTANCE Pathwaysregulatingthecomplexandsometimesparadoxicaleffectsofcytokinesarepoorlyunderstood.Accumu-
latingevidenceindicatesthatthebiologicalconsequencesoftype1interferon(IFN)exposureareshapedbymodifyingthecon-
centrationsofparticularSTATstochangeaccesstothedifferentsignalingmolecules.Theresultsoftheexperimentspresented
conclusivelydemonstratethatNKcellIFN-canbeinducedthroughtype1IFNandSTAT4attheﬁrstsiteofinfectionduringa
periodwithhighSTAT4butpriortoinductionofelevatedSTAT1inthecells.Theresponsemediatesaroleinviraldefense.
Thus,averyearlypathwaytoandsourceofIFN-inevolvingimmuneresponsestoinfectionsareidentiﬁedbythiswork.The
informationobtainedhelpsresolvelong-standingcontroversiesandadvancestheunderstandingofmechanismsregulatingkey
type1IFNfunctions,indifferentcellsandcompartmentsandatdifferenttimesofinfection,foraccessingbiologicallyimportant
functions.
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N
Kcellsoftheinnateimmunesystemhavebothantimicrobial
and immunoregulatory functions (1, 2). They mediate these
as a result of their cytotoxicity and cytokine-producing abilities,
butthepathwaysactivatingandpromotingengagementofNKcell
effects are incompletely understood. During responses to viral
infections, the antiviral cytokines, type 1 interferons (IFN-/)
stimulate both cellular resistance to viruses and NK cell cytotoxic
function (3–5). The cytokines also have the potential to either
promoteorinhibitIFN-productionindifferentcelltypes(5–7),
but type 1 IFN enhancement of IFN- might not be important in
NK cell responses to viruses because infections eliciting high sys-
temic type 1 IFN levels are not associated with systemic NK cell
IFN-production(8,9).Instead,NKcellIFN-productioninthe
presenceofhightype1IFNiselicitedwheninterleukin-12(IL-12)
is induced and is dependent on this cytokine (4, 8). As a conse-
quence,NKcellIFN-hasnotbeenreadilydetectedduringinfec-
tions with viruses failing to stimulate IL-12 production.
The ﬁrst described signaling pathway engaged by type 1 IFN
binding to the speciﬁc heterodimeric receptor stimulates phos-
phorylation of the signaling and transcription factors STAT1 and
STAT2 (5, 10). Complexes, including these activated intermedi-
aries,elicitexpressionofawiderangeofgeneproductsimportant
fordeliveringdirectantiviralfunctions.Inaddition,certaintype1
IFN immunoregulatory effects, including activation of NK cell
cytotoxicity, are dependent on STAT1 (4, 11). There are a total of
seven STAT molecules—STAT1 through STAT6, with two
STAT5s—and type 1 IFNs conditionally activate all of these (5,
12), including STAT4, an important intermediary in IL-12 stim-
ulation of NK cells as well as type 1 IFN stimulation of certain T
cell populations for IFN- production (4, 13–15). Previous work
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onstratedthatNKcellsexpresshighbasallevelsofSTAT4andthat
theirexposuretotype1IFNsactivatesSTAT4(9).Nevertheless,it
has only been possible to identify the type 1 IFN induction of NK
cell IFN- production during acute viral infections of STAT1-
deﬁcientbutnotofSTAT1-completemicebecausetheconcurrent
induction of STAT1 by type 1 IFN and/or IFN- negatively regu-
lates the response (6, 9). These results leave open the intriguing
question of why a pathway from type 1 IFN to STAT4 activation
underbasalNKcellconditionswouldbeevolutionarilypreserved
when it is rapidly turned off at times of type 1 IFN production.
Withthehypothesisthattype1IFNinductionofNKcellIFN-
isinplacetoaccesslow,regionallevelsofthecytokineasinfections
areinitiated,studieswereundertakentoexamineresponsesatthe
earliest times of viral infection under immunocompetent condi-
tions. The system used for study was intraperitoneal (i.p.) infec-
tion of C57BL/6 (B6) mice with lymphocytic choriomeningitis
virus (LCMV) (7, 9, 16, 17). This infection has been well charac-
terizedandisofrelevancetothehumanconditionbecauseLCMV
can cause signiﬁcant morbidity and mortality, particularly in im-
munodeﬁcient individuals (18–20). The virus is a potent inducer
of type 1 IFN, with systemic levels produced in serum and spleen
for several days after i.p. infection (7, 9, 17). In contrast, LCMV is
a poor inducer of IL-12, with low to undetectable levels of the
cytokine produced (8, 16), and NK cell IFN- expression is also
low to undetectable in the serum and spleens of LCMV-infected
mice (8, 9). Because the initial site of virus entry is the peritoneal
cavity,thestudiesfocusedonpreviouslyuncharacterizedeventsat
this location.
The results of the experiments reported here reveal unique
compartmentalinnatecytokineresponses,withIFN-andIFN-
production and NK cell IFN- expression detected at 24 h after
infection and peaking at 30 h after infection. Studies under con-
ditions of blocked type 1 IFN receptor access and/or deﬁciency in
STAT4 conclusively demonstrated that NK cell IFN- expression
was dependent on the type 1 IFNs and STAT4. The pathway en-
hanced the antiviral state. Interestingly, in comparison to other
peritoneal populations, STAT1 induction in NK cells was delayed
and separated from the NK cell IFN- response by 10 to 12 h.
Thus,theresultsuncoverakeyrolefortype1IFNactivationofNK
cell IFN- and mechanistically resolve important issues concern-
ing the earliest pathways to, sources of, and functions for IFN-.
RESULTS
Innate cytokine responses to LCMV infection in the peritoneal
cavitypeakearlyandincludeNKcellIFN-expression.Tochar-
acterize responses at the earliest times after infections, lavage ﬂu-
idsandcellswerecollectedfromperitonealcavitiesofB6micethat
had been uninfected or infected i.p. with 5  104 PFU LCMV at
theindicatedtimespriortoharvest.Theﬂuidsweretestedtoeval-
uatecytokinesreleasedatthesite.TheIFN-levelsweremeasured
usingacytometricbeadassay(CBA).Lowbutconsistentlydetect-
ablelevelsofIFN-werefoundpeakingat30hafterLCMVinfec-
tion (Fig. 1A). Enzyme-linked immunosorbent assays (ELISAs)
were used to measure IFN- and IFN-. In contrast to the re-
portedextendedkineticsofsystemiclevelsofthesecytokines(7,9,
17)aswellasthetype1IFNsdetectedthrough48hafterinfection
in serum samples taken from mice used for these experiments
(datanotshown),concentrationsofIFN-andIFN-intheperi-
toneum reached their peak values of 340 and 69 pg/ml, respec-
tively, at 30 h after challenge and were sharply conﬁned to the 6-h
periodssurroundingthatpoint(Fig.1A).ThelevelsofIL-12p70,a
known inducer of IFN-, were acquired from the CBAs. All sam-
ples were below the limit of detection for the assay, with no de-
tectable levels in a large majority of samples isolated after 20 to
48hofinfection(Fig.1A).Thus,theperitonealcytokineresponses
to LCMV infection include early induction of IFN-, with kinet-
icallyoverlappingIFN-andIFN-production,butundetectable
IL-12.
To deﬁne the major cell populations contributing to IFN-
production, peritoneal excudate cells (PECs) from uninfected
(0h)miceandmiceinfectedwithLCMVfor20,24,30,36,40,and
48 h were isolated, stained for NK1.1 and T cell receptor  (TCR-
), ﬁxed, and permeabilized to stain for cytoplasmic IFN- (see
Materials and Methods for staining and gating strategies). Total
lymphocytes were evaluated with an extended lymphocyte gate.
The NK cell subpopulations were identiﬁed as NK1.1 TCR-
and the T cell subpopulations as NK1.1 TCR-. Lymphocytes
isolated from uninfected mice, including total, NK, and T cells,
did not basally express detectable IFN-; the positive frequencies
for all populations were 4% (Fig. 1B and C). By 24 h after chal-
lenge with LCMV, approximately 14 to 37% of the NK cells ex-
pressedmoderatetohighlevelsofintracellularIFN-.Thepeakof
this NK cell response was at 30 h after infections, when 28 to 43%
of the NK cells expressed IFN-. The response was resolving at 36
to48h.IncontrasttotheNKcells,neithertotallymphocytenorT
cell populations had high IFN- levels at any of the times exam-
ined (Fig. 1B and C). These results demonstrate that during
LCMV infection, peritoneal NK cells respond with IFN- expres-
sionandarethemajorproducersofthecytokineintheperitoneal
cavity.
Type 1 IFN responsiveness is required for induction of NK
cell IFN- expression. Because induction of the biologically ac-
tive IL-12p70 heterodimer can be accompanied by higher-level
IL-12p40 subunit production (8), representative lavage samples
from 0, 24, 30, 36, 40, and 48 h following LCMV infection were
tested in an ELISA for the subunit. Consistent with our earlier
studies(8),allsampleshadIL-12p40levelsatorbelowthelimitof
detection for the assay (data not shown). To determine if biolog-
ically relevant IL-12 was induced below detection limits, unin-
fected and LCMV-infected mice were treated with control anti-
body or anti-IL-12p40 antibody neutralizing the function of
biologicallyactiveIL-12p70(8).AsapositivecontrolforanIL-12-
inducedIFN-response(21,22),miceweregivenlipopolysaccha-
ride (LPS) i.p. at 6 h prior to harvest. In comparison to LCMV
infection, LPS treatment induced higher levels of IFN- in lavage
ﬂuids (Fig. 2A) and higher proportions of NK cells expressing
IFN-(Fig.2B).TheenhancedresponsetoLPSwasblockedbythe
anti-IL-12 treatment. In contrast, the IFN- response to LCMV
infectionwasresistanttotheanti-IL-12treatment(Fig.2AandB).
Thus,IL-12isnotrequiredfortheNKcellIFN-responseelicited
by the virus.
Twodifferentapproacheswereusedtoevaluatetheroleoftype
1 IFNs in stimulating NK cell IFN- within mice blocked in their
responsiveness to the cytokines. The ﬁrst examined responses in
cells from uninfected and 30-h LCMV-infected immunocompe-
tent mice that had been treated with control antibodies or anti-
bodies blocking access to the type 1 IFN receptor, anti-IFNAR
(23). As shown in Fig. 3A, the infected control-treated mice had
theexpected25to30%oftheirNKcellsexpressingIFN-,butthis
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antibodies against IFNAR. The second approach examined re-
sponses in mice that were blocked in type 1 IFN responsiveness
as a result of genetic mutation of the type 1 IFN receptor
(IFNAR/) (24). In comparison to the up to 36% of NK cells
expressing IFN- in wild-type (WT)-infected mice, 1% of the
NK cells in the infected IFNAR/ mice expressed IFN- at 30 h
afterLCMVinfection(Fig.3B).Thus,blockingtype1IFNrespon-
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FIG1 CytokineexpressionintheperitonealcavityduringLCMVinfection.C57BL/6micewereuninfected(time0)orinfectedi.p.withLCMVfortheindicated
times.Peritoneallavageﬂuidsandcellswerecollected.(A)Cytokinelevelsinlavageﬂuidsweremeasured.IFN-andIL-12p70levelswerequantiﬁedbyCBA,and
IFN- and IFN- levels were quantiﬁed by ELISA. CBA data were pooled from six independent experiments with the following total numbers of individual
samples: n 11 (time 0), 2 (20 h), 9 (24 h), 8 (30 h), 17 (36 h), 3 (40 h), and 5 (48 h). ELISA data were pooled from six independent experiments with total n 
11 (0 h), 2 (20 h), 6 (24 h) 11 (30 h), 11 (36 h), 3 (40 h), and 5 (48 h). (B and C) Flow cytometry was used to deﬁne subsets expressing intracellular IFN-. Cell
surface staining of NK1.1 and TCR- followed by cytoplasmic staining for IFN- expression was carried out. Analysis was based on subsets identiﬁed in an
extendedlymphocytegate.(B)RepresentativecytoplasmicIFN-expressionwithintotallymphocytes,Tcells,andNKcells(solidblackline)comparedtoisotype
controlsforstaining(dashedblackline).ThenumbersshownarepercentagesofIFN--expressingcells.(C)ProportionsofperitonealNKcellsexpressingIFN-
wereevaluatedbypoolingresultsfromeightindependentexperimentswithtotaln13(0h),2(20h),4(24h),10(30h),15(36h),5(40h),and5(48h).Filled
circles are results from individual animals. Bars are means  standard errors of the means (SEM).
FIG2 EffectsofIL-12blockadeonperitonealIFN-responsestoLCMVorLPS.Micewereuninfected,infectedwithLCMVfor30h,ortreatedwithLPSat6h
priortoharvest.Theywereadministeredanti-IL-12orcontrolantibodies12hpriortoLCMVinfectionand36hpriortoLPStreatment.Peritoneallavageﬂuids
andcellswereharvestedattheindicatedtimes.(A)IFN-levelsinthelavageﬂuidsweredeterminedbyCBA.Eachpointrepresentsanindividualanimal.(B)NK
cellsubsetswereidentiﬁedandexaminedforIFN-levelexpressionbyﬂowcytometry.Representativeﬂowcytometricplotsfromindividualanimalsareshown
on the left, and a quantiﬁcation of the data is shown in bar graphs on the right. Results presented for both panels are pooled from two independent experiments
having groups each having n  3. Means  SEM are shown. *, P  0.02; ***, P  0.0001.
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cell IFN- expression after LCMV infection.
Becausetype1IFNsstimulateawiderangeofeffects,including
those important for antiviral defense, the direct consequences of
NKcellresponsivenesstothesecytokinesrequiredexaminationin
the context of a WT environment. Therefore, experiments evalu-
ated IFN- induction in peritoneal WT (IFNAR/) and IF-
NAR/ cells after their isolation and adoptive transfer into WT
recipientmice(Fig.3C).Cellsfromrecipientanddonormicewere
distinguished by expression of the CD45.1 or CD45.2 allele, with
recipient mice being CD45.1 and donor mice being CD45.1
(Fig. 3C). For these studies, WT and IFNAR-deﬁcient PECs were
prepared and transferred into WT recipient mice prior to LCMV
infection. None of the populations expressed IFN- when recipi-
ents remained uninfected (Fig. 3C; 0 h after LCMV). When WT
PECs were transferred into WT recipients, both donor and recip-
ient NK cells expressed IFN- at 30 h after infection, with overall
mean expression of 23 and 21%, respectively (Fig. 3C). In con-
trast, transferred NK cells isolated from IFNAR-deﬁcient mice
were signiﬁcantly decreased in their ability to express IFN-, with
expression averaging approximately 4% compared to 22% of WT
recipient NK cells (Fig. 3C). Taken together, the studies conclu-
sivelyprovethattype1IFNsignalingwithinperitonealNKcellsis
required for the induction of IFN- expression during LCMV
infection.
NK cell IFN- expression requires STAT4. To determine the
role of STAT4 in NK cell IFN- expression, responses in mice
lacking STAT4 as a result of genetic mutation (STAT4/) (13)
were evaluated. Here, the PECs were isolated from uninfected
mice and mice at 30 or 36 h after LCMV infections (Fig. 4A). NK
cellsfrominfectedSTAT4-deﬁcientmicewereinducedtoexpress
much lower levels of IFN- and did so in lower frequencies than
NKcellsfrominfectedWTmice(Fig.4A).Todeﬁnetheeffectsof
STAT4 loss within NK cells in a WT environment of infection,
adoptive transfer experiments were carried out using PEC donor
cells isolated from WT or STAT4-deﬁcient mice and then deliv-
ered into WT recipient mice. The donor cells were identiﬁed by
lack of CD45.1 expression and the recipient cells by CD45.1 ex-
pression(Fig.4B).NoneofthepopulationsexpressedIFN-when
recipients remained uninfected (Fig. 4B; 0 h after LCMV infec-
tion). When WT PECs were transferred into WT recipient mice,
both recipient and donor NK cells expressed normal levels of
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weretransferred,donorNKcellsproducedsigniﬁcantlylowerlev-
els of IFN- compared to WT recipient NK cells in response to
infection (Fig. 4B). Hence, STAT4 expression within peritoneal
NK cells is necessary for optimal IFN- induction.
The STAT1 and STAT4 levels are differentially expressed in
cell subsets during LCMV infection. Because our previous stud-
ieshaveshownthatapathwayfromtype1IFNthroughSTAT4for
NK cell IFN- expression in the spleen is associated with high
basalSTAT4levelsbutblockedbyincreasingSTAT1levelsduring
infections (9), intracellular STAT levels were examined in the
peritonealpopulationsbyﬂowcytometricapproaches.Theexper-
iments demonstrated high basal STAT4 levels in NK cells
(Fig. 5A). The trait was unique to NK cells, with only low propor-
tions of total lymphocytes and T cells expressing STAT4 and only
doing so at lower levels, and NK cells retained their unique high
levels of STAT4 throughout infection (Fig. 5A). In contrast, all
populations isolated from uninfected mice were low for STAT1,
but expression in the NK cells was always slightly lower (Fig. 5B).
Following LCMV infection, the total lymphocyte and T cell pop-
ulationsrapidlyelevatedSTAT1expression,with80to95%ofthe
populations expressing high levels of STAT1 by 40 h after infec-
tion (Fig. 5B to D). The peritoneal NK cells also had STAT1 levels
inducedduringtheinfection,butincomparisontotheotherpop-
ulations, there was a delay, requiring upwards of 8 to 16 h longer
than total lymphocytes and T cells to reach 50% high levels of
STAT1-expressing cells (Fig. 5B to E). Thus, the NK cell popula-
tions uniquely express high levels of STAT4 basally and after in-
fection. Moreover, although all populations have elevated STAT1
after infection, induction in NK cells is delayed.
The peritoneal IFN- response promotes resistance to
LCMVinfection.Afteri.p.infection,LCMVwasdifﬁculttodetect
in lavage ﬂuids at 20 and 24 h, but titers rapidly increased by 30 h
and subsequently decreased (Fig. 6A). To determine the physio-
logic relevance of the peritoneal IFN- response, viral burdens
weremeasuredinsamplescollectedfromWTmiceandmiceren-
deredunresponsivetoIFN-asaresultofgeneticmutationofthe
IFN- receptor (IFN-R/) (25). The IFN-R-deﬁcient mice
had signiﬁcant increases in LCMV titers of approximately 1 log at
30hafterinfection(Fig.6A).Experimentsevaluatingtherequire-
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antibody treatments, antibodies to NK1.1 depleted the following:
(i) the NK cells from the PECs isolated from uninfected and in-
fected mice (Fig. 6B), (ii) the major population expressing intra-
cellular IFN- after infection (Fig. 6B), and (iii) the levels of de-
tectableIFN-inlavageﬂuidscollectedat30hfollowingchallenge
(Fig.6C).Theeffectswereaccompaniedbyproportionalincreases
inviraltiters(Fig.6C).Takentogether,thesestudiesdemonstrate
that the IFN- responses have an impact on controlling the viral
burden in the peritoneal cavity during LCMV infection and that
NK cells are required for the optimal IFN- response, and its
effects.
DISCUSSION
In the work presented above, the interplay between cytokines and
intracellular signaling molecules in the regulation of NK cell acti-
vation and function is deﬁned at the earliest site of viral infection
in immunocompetent mice. Production of IFN-, IFN-, and
IFN- in the peritoneal cavity was shown to peak at 30 h after
LCMVinfection.NKcellswerethemajorproducersofIFN-and
uniquely expressed high levels of STAT4. The pathway for induc-
tion of NK cell IFN- production was dependent on responsive-
ness to type 1 IFNs and on the STAT4 signaling molecule. The
elicitedIFN-enhanceddefensebecauselossofresponsivenessto
the factor resulted in increased viral burdens. Thus, type 1 IFN
inductionofIFN-productionbyNKcells,dependentonSTAT4,
is conclusively proven to occur and to lead to downstream effects
under immunocompetent conditions.
Previous work from this laboratory has established that under
basal conditions, splenic NK cells express high STAT4 and low
STAT1 levels and preferentially activate STAT4 over STAT1 after
ex vivo exposure to type 1 IFNs (9). Nevertheless, it has only been
possible to identify type 1 IFN activation of STAT4 and IFN- in
the spleens of STAT1-deﬁcient mice during LCMV infection be-
causethetype1IFNsandIFN-induceSTAT1levelstoblockthe
pathwaytoSTAT4(9).Theresultsreportedhereanswertheques-
tion of why a pathway from type 1 IFN to STAT4 for IFN- ex-
pression would be maintained when it is rapidly turned off by
concurrent STAT1 induction; it is used to locally access a short
burst of IFN- at very early times after infection. In this case,
“locally” is the peritoneal cavity. In addition to the detectable NK
cellIFN-response,innateresponsestoLCMVatthissitediffered
from the well-characterized responses in spleen and serum (7, 9,
17) with regard to the kinetics and magnitude of type 1 IFN pro-
ductionandthekineticsofSTAT1inductioninNKcells(9).Type
1 IFN production in the peritoneal cavity was very early and of
shortduration—detectableat24h,peakingat30h,andresolving
by 36 h after infection (Fig. 1)—and although total lymphocytes
and T cells had dramatically elevated STAT1 levels early, induc-
tion was delayed by 8 to 16 h in the NK cells (Fig. 5). Thus, in
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allows type 1 IFN to access STAT4 prior to STAT1 induction in
NK cells (Fig. 7).
WhywasSTAT1elevationdelayedintheNKcellscomparedto
the other PEC populations examined? Promoter sequences in the
STAT1 gene speciﬁc for STAT1 complexes may act to enhance
STAT1 induction whenever STAT1 is activated (26). Thus, any
cytokine signaling through STAT1 would be expected to induce
elevated STAT1 levels. In addition to type 1 IFN receptors, recep-
tors for IFN- also activate STAT1 (10). The results presented
here suggest that NK cells might ﬁrst respond to type 1 IFN expo-
sure with IFN- because of their high STAT4 levels, but once
IFN- is induced, it acts back on the cells to induce STAT1. This
wouldexplainthedelayinSTAT1inductioninNKcellscompared
to other subsets. Alternatively or additionally, it might just take
longer for type 1 IFN to induce STAT1 in populations with high
STAT4levels.TheNKcellsinboththespleen(9)andperitoneum
(Fig. 5) consistently have lower levels of STAT1. Because the
spleen is a secondary compartment of infection, most of the NK
cellsmaybeexperiencingcytokinesproducedearlieratothersites
and/or not be synchronized to make a detectable short burst of
IFN-inthiscompartment.Inanycase,itisremarkablethatthere
is a window of opportunity for IFN- production under the con-
ditionsintheperitoneumgiventhelinkbetweenthisresponseand
shutting it off. The pathway suggests that there will be a very early
source of NK cell IFN- whenever type 1 IFNs are induced.
Our studies are helping to resolve conﬂicting reports in the
literatureonpotentialtype1IFNconsequencesforIFN-expres-
sion(5,6,9),addinginformationtothegrowingliteraturereport-
ing cellular differences in type 1 IFN responses (27, 28) and ad-
vancing the mechanistic understanding of how the biological
effects of STAT cytokines are regulated to access diverse and par-
adoxical effects as needed. Type 1 IFNs have long been known to
exert antiviral effects and enhance NK cell cytotoxicity through
the activation of STAT1 (4, 5, 11). The NK cells, however, are
positioned to respond to type 1 IFNs with STAT4 activation be-
causehighbasallevelsofSTAT4areassociatedwiththetype1IFN
receptor(9).IncreasingtheendogenouslevelsoftotalSTAT1pro-
tein negatively regulates STAT4 access in part by displacing
STAT4 from the receptor, and this induction of STAT1, as ob-
servedinthespleen,isbeneﬁcialbecauseitprotectsfromdysregu-
lated systemic IFN- production and cytokine-mediated disease
(9).Incontrast,theresultsreportedhereshowthatthetype1IFNs
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at different times of infections. (B) NK cell depletion in the peritoneum. The
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sented in the upper panel. Flow graphs show results from individual samples.
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FIG 7 Compartmental differences in innate immune response to LCMV
infection. Shown is a schematic representation of the differences in the im-
mune response to LCMV in the peritoneal cavity compared to the spleen. The
results presented here studying the peritoneal cavity show that both type 1
IFNs and the viral burden peak at 30 h. This is correlated with an early peak in
IFN- production in NK cells. NK cell production of IFN- occurs before
STAT1levelshaverisen.Previousworkwiththespleenhasshownthatamore
vigorous peak in viral load and type 1 IFNs is seen between 2 and 3 days after
LCMV infection with a concurrent rise in STAT1 (7). Type 1 IFNs are unable
toaccessSTAT4-dependentIFN-productionduetotheearlierriseinSTAT1
levels. The response in the peritoneum promotes antiviral defense. The re-
sponse in the spleen protects from dysregulated cytokine production and
cytokine-mediated disease.
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STAT1 induction and that this pathway promotes resistance to
infection. Recent studies have shown that similar STAT4-STAT1
regulation is in place in humans; type 1 IFNs induce STAT4 acti-
vation in NK cells isolated from healthy individuals, but the re-
sponse is diminished in NK cells from individuals chronically in-
fected with hepatitis C virus. The activation of STAT4 negatively
correlates with STAT1 levels in these populations (29). Thus,
modulation of STAT4 and STAT1 concentrations in different cell
typesunderdifferentconditionsofinfectionsinmiceandhumans
helps explain how type 1 IFNs can enhance or antagonize IFN-
stimulation, and the studies with mice provide explanations for
how the balance, in both directions, works to the beneﬁt of the
host. A change in relative STAT ratios might also play a role in
conditioning NK cells to modify type 1 IFN responses from pro-
moting cytokine production to enhancing cytotoxic function.
In addition to our earlier studies with STAT1-deﬁcient mice,
therehavebeenafewotherreportssuggestingaroleoftype1IFN
in NK cell IFN- expression. One examined a number of activa-
tion responses, including intracellular IFN-, of type 1 IFN
receptor-deﬁcient compared to WT NK cells following in vitro
exposure to vaccinia virus and dendritic cells (30). Early in vivo
IFN-inductionhasbeenreportedinthemouseperitoneumdur-
ing different viral infections (31), and intracellular IFN- expres-
sion by splenic NK cells has been observed following treatments
with the chemical analogue of viral nucleic acids, polyinosinic-
polycytidylic acid [poly(I · C)] (32, 33). These in vivo studies,
however, have been done under conditions where the type 1 IFN
effects were not delineated from those that might have been me-
diated by other cytokines induced under the experimental condi-
tions used, including reported IL-12. In one study with
poly(I · C) (32), the intracellular NK cell IFN- expression was
shown to be blocked by treatments with antibodies neutralizing
type 1 IFN function, but the consequences of the treatments on
other cytokine responses were not evaluated. Here, in vivo re-
sponses under which the type 1 IFN receptor was blocked were
evaluated by different approaches, including adoptive transfer of
peritoneal populations from WT or type 1 IFN receptor-deﬁcient
mice into WT-infected mice (Fig. 3). This method allows direct
comparisonofdonorandrecipientcellsinthecontextofthecom-
plete endogenous immune responses. Thus, to our knowledge,
this is the ﬁrst demonstration of type 1 IFNs inducing IFN- pro-
duction from NK cells under immunocompetent conditions of
viral infection.
The studies do not exclude possible roles for accessory cyto-
kines in enhancing type 1 IFN induction of IFN-. Certainly,
IL-12 is an activator of STAT4 and a potent inducer of IFN- (13,
34). The cytokine IL-18 can enhance the stimulation of IFN- by
either type 1 IFNs or IL-12 (7, 35–37), and new studies decipher-
ingpathwaysfromdifferentsensorshavedemonstratedsynergism
betweentype1IFNsandIL-12forIFN-inductioninhumancells
(38). The results presented here, however, suggest that there may
be a short burst of IFN- induced by type 1 IFNs independent of
IL-12,andourpreviousworkexaminingmurinecytomegalovirus
infections of mice has shown that induced type 1 IFNs promote
NK cell cytotoxicity but IL-12 is required for splenic and systemic
NK cell IFN- (3, 4). The experiments carried out here neutraliz-
ingIL-12invivoshowthatIL-12doesnotplayaroleintheLCMV-
induced NK cell IFN- response (Fig. 2). Interestingly, the posi-
tive controls for these studies (i.e., effects on LPS induction of
IFN-intheperitonealcavity)(Fig.2)demonstratethatwhenitis
elicited,IL-12isimportantinelicitingaperitonealNKcellIFN-,
but also that there is residual NK cell IFN- after neutralization.
ThisisconsistentwithearlyreportsofincompleteIFN-blockade
by IL-12 neutralization following LPS treatment in other settings
(21)andtheknownLPSinductionofIFN-(39).Takentogether,
the studies suggest that IL-12 is an important inducer of NK cell
IFN- if elicited and the critical cytokine for IFN- induction
once STAT1 levels are increased. There are likely to be additional
regulatory factors in play, however, as the presence of STAT1
eventually results in reduced IFN- induction by either type 1
IFNs or IL-12 (6). Thus, much remains to be done to map the
complex interactions between type 1 IFN and IL-12 for shaping
NK cell responses, but eliciting different type 1 IFN and IL-12
responses may be part of directing the magnitude of, and contin-
ued access to, the NK cell IFN- response.
The peritoneal responses reported here demonstrate that by
being receptive to early type 1 IFN signaling with IFN- produc-
tion, NK cells can serve as sensors for and responders to the pres-
ence of viral pathogens. The studies surprisingly reveal a previ-
ously elusive role for NK cells in early defense against LCMV. In
comparisontootherviralinfectionsincompartmentsoutsidethe
peritoneal cavity, LCMV has been shown to be relatively insensi-
tive to the direct antiviral effects of NK cells (40–42) or IFN-
(43). Our previous attempts to access NK cell IFN- in defense
against LCMV have shown that administration of IL-12 prior to
infection can induce the response to result in under a 1-log de-
crease in splenic viral titers (44). In this report, infection-induced
IFN-, dependent on NK cells, was shown to proportionally limit
viral burden at this ﬁrst site of infection. Thus, though modest,
there is a documented effect of the NK cells and IFN- during
LCMVinfection.Themechanismfortheantiviraleffectmediated
by IFN- is not known. Given the rapid kinetics, it is likely to be a
resultoftheactivationofdirectantiviraleffectsininfectedcellsor
macrophagesratherthanenhancementofadaptiveimmunefunc-
tions resulting from promoting major histocompatibility com-
plex (MHC) class 1 expression or CD8 T cell effector functions
(45). It remains to be determined whether or not the NK cell
IFN- elicited by type 1 IFNs will be a more important ﬁrst re-
sponse in defense against other more sensitive viral infections
and/or for promoting immunoregulatory functions.
Insummary,thesestudiesdiscoveranovelpathwayforNKcell
stimulation at an initial site of infection. Moreover, they advance
understanding of the regulation of type 1 IFN responses and pro-
vide critical insights into how the immune response is ﬁnely reg-
ulatedtodelivermaximalprotectionwithoutbeingdetrimentalto
the host.
MATERIALS AND METHODS
Mice. Speciﬁc-pathogen-free C57BL/6 (B6) (C57BL/6NTac) and B6.SJL-
Ptprca/BoyAiTacmice,whichareC57BL/6micethatexpressthecongenic
CD45.1 allele of the Ptprc (protein-tyrosine-phosphatase, receptor type c
locus) gene, were purchased from Taconic Laboratories (Germantown,
NY).BreedingpairsoftheStat4/mice(13)ontheB6backgroundwere
a gift from Mark H. Kaplan of Indiana University, B6 IfngR/ mice (25)
withcontrolWTmicewerepurchasedfromtheJacksonLaboratories(Bar
Harbor, ME), and Ifnar/ mice (24) on the B6 background were a gift
from Murali-Krishna Kaja of the University of Washington. All mice ex-
cept B6.SJL mice expressed the CD45.2 allele. Genetically mutated mice
were bred and maintained in isolation facilities at Brown University
through brother-sister mating. All mice used in experiments were 5 to 12
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housed in the animal care facility for at least 1 week before use. Handling
ofmiceandexperimentalprocedureswereconductedinaccordancewith
institutional guidelines for animal care and use.
Virus, infections and treatments. For LCMV infection experiments,
mice were either uninfected (0 h after infection) or infected i.p. with 5 
104 PFU of LCMV Armstrong strain, clone E350 (7, 9, 17). For IL-12
blockingexperiments,animalswereinjectedwitheither750gor1mgof
anti-IL-12p40(anti-IL-12/23,cloneC17.8;BioXCell,WestLebanon,NH)
orcontrolratIgG2a(clone2A3;BioXCell)antibodies12hpriortoLCMV
infection and 36 h prior to treatment with 20 g of LPS (from Salmonella
enterica serovar Enteritidis; Sigma, St. Louis, MO). Samples from LPS-
treatedmicewereharvested6haftertreatment(22).(Thelevelsofefﬁcacy
of treatment with either 750 g or 1 mg of anti-IL-12 were similar.) For
IFNAR blocking experiments, animals were injected with 250 g of anti-
IFNAR1(cloneMAR1-5A3;LeincoTechnologies,St.Louis,MO)orcon-
trol IgG antibodies 12 h prior to LCMV infection. For NK depletion ex-
periments, animals were injected with 500 g of anti-NK1.1 (clone
PK136;BioXCell)orcontrolIgG2aantibodiesat36or12hpriortoLCMV
infection.
Sample preparation. PECs were extracted on the indicated days of
infection. LCMV-infected and control uninfected (0) mice were anesthe-
tized and bled retro-orbitally to collect serum samples. Mice were hu-
manely sacriﬁced, by cervical dislocation after anesthetization, and the
peritonealcavitywaslavagedwith5mlofcoldserum-freeRPMImedium
(Gibco, Invitrogen, Carlsbad, CA). Mice were gently agitated to increase
PECsuspensioninlavagemedium.Foranalysisofsurfacemarkerexpres-
sion or total STAT levels, PECs were resuspended in staining buffer con-
taining 2% heat-inactivated fetal bovine serum (FBS) and then prepared
forﬂowcytometricanalysisasdescribedbelow.Forexaminationofintra-
cellular IFN-, PECs were resuspended in complete media containing
5 g/ml brefeldin A (Sigma, St. Louis, MO), without additional stimula-
tion,for4hat37°C.Cellswerethenstainedasdescribedbelow.Peritoneal
lavage ﬂuids and serum samples were aliquoted and stored at 80°C for
later use in cytokine and viral titer measurements.
Adoptive transfers. Total donor PECs from uninfected mice
(CD45.2) were isolated as described above and resuspended in 300 lo f
RPMI medium. These cells were injected i.p. into uninfected recipient
mice (CD45.1). Recipient mice were rested for 1 h and either left unin-
fected or infected with LCMV as described above. Staining to identify
donor and recipient cell populations was performed as described below
using an anti-CD45.1–ﬂuorescein isothiocyanate (FITC) antibody.
Flow cytometric analysis. Detection of surface markers, intracellular
IFN-, and intracellular total STAT1 and STAT4 was done with minor
modiﬁcations as previously described (9, 46). Brieﬂy, PECs were incu-
bated with 2.4G2 antibody (BioXCell, West Lebanon, NH) to block non-
speciﬁc binding to the Fc receptor. Cell surface staining was then per-
formedwithantibodiesspeciﬁcforthefollowing:TCR-–FITC,TCR-–
peridinin chlorophyll protein (PerCP), NK1.1-phycoerythrin (PE) (all
from eBioscience, San Diego, CA), TCR-–FITC, and CD45.1-FITC (BD
Biosciences, Franklin Lakes, NJ). For cell surface staining only, cells were
ﬁxedwith2%paraformaldehyde.ForintracellularstainingofIFN-,cells
were ﬁxed and permeabilized with Cytoﬁx/Cytoperm (BD Biosciences)
and then stained with IFN-–allophycocyanin (APC) (BD Biosciences).
For intracellular staining of total STAT1 and STAT4, cells were ﬁxed and
permeabilized with Cytoﬁx/Cytoperm and then further ﬁxed and perme-
abilizedwithice-coldpuremethanol.Subsequentstainingwasperformed
with combinations of STAT1-PE and STAT4-APC (custom prepared by
BD Biosciences). The following isotype controls were included in each
experiment: mouse IgG2a, mouse IgG2b, mouse IgG1, rat IgG1, rat
IgG2a,ratIgG2b,andhamsterIgG(BDBiosciencesoreBioscience).Sam-
ples were acquired using a FACSCalibur (BD Biosciences) with the Cell-
QuestProsoftwarepackage(BDBiosciences).Laseroutputswere15mW
at 488- and 635-nm wavelengths. At least 120,000 events were collected
within a live-cell gate that was determined by forward and side scatter.
AnalysisofﬂowcytometricdatawasperformedusingFlowJo9(TreeStar,
Inc., Ashland, OR).
To ensure proper identiﬁcation of the NK cell population in PECs,
NK1.1-positive cells were costained with markers identifying TCR-/
and TCR-/ T cells. A lymphocyte gate was set to maximize inclusion of
NK1.1 cells at different times after infection, and it was identiﬁed as an
“extendedlymphocytegate.”Usingthisscheme,5%oftheNK1.1cells
were TCR- under naive conditions; after LCMV infection, the popula-
tion was reduced to 2%, and the cells were not producing IFN- (data
not shown). NK1.1 cells that were TCR- (NK T cells) represented
approximately30%ofthetotalNK1.1populationatday0.AfterLCMV
infection, this population was again diminished to 5%, and the IFN-
produced by these cells represented only about 3% of the total IFN-
cells. Thus, all experiments deﬁned NK cells to be NK1.1 TCR-.
Cytokine measurements. IFN- and IL-12p70 were measured in the
peritoneal lavage ﬂuid or the serum using the mouse inﬂammation kit
cytometric bead assay (BD Biosciences). The limits of detection were
2.5 pg/ml for IFN- and 10.7 pg/ml for IL-12p70. IFN- and IFN- were
measured in the peritoneal lavage ﬂuid or the serum using the VeriKine
mouse IFN- or mouse IFN- ELISA kits, respectively (PBL Interferon-
Source, Piscataway, NJ). The limits of detection for these assays were
12.5 pg/ml for IFN- and 15.6 pg/ml for IFN-. The IL-12p40 ELISA,
with a limit of detection of 100 pg/ml, was done as previously described
(8).
LCMV plaque assay. LCMV titers were determined as previously de-
scribed (7, 17). Brieﬂy, peritoneal lavage ﬂuids were thawed from storage
at 80°C and serially diluted. Samples were overlaid onto Vero cell
monolayersandincubatedat37°Cfor1.5h.Plaqueswereallowedtoform
upon overlay of samples with a 50:50 mixture of agarose-medium 199
(Sigma)for3daysandthenvisualizedusingneutralredstaining(Sigma).
Included in each assay were positive LCMV control samples and negative
controls (uninfected animals).
Statistical analysis. All analyses were performed using Prism 5
(GraphPadSoftware,LaJolla,CA).Statisticalsigniﬁcancewasdetermined
using the two-way analysis of variance (ANOVA) test.
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